États-Unis · Plateformes & données · Finviz

Xenon to Report Q3 2026 Financial Results on November 9, 2026

Publié par Finviz · États-Unis il y a 9 h

About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and…

Lire l'article complet sur Finviz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finviz.com)

Xenon to Report Q3 2026 Financial Results on November 9, 2026

À lire aussi

Empire State Realty Trust FFO of $0.20 beats by $0.02, revenue of $193.05M beats by $4.34M

AMD Reports Tuesday. Here's the Number That Will Show Whether It's Gaining on Nvidia

Traders rushing into a leveraged ETF to make a bullish bet on the Nasdaq-100 just got burned

People Inc earnings missed by $8.96, revenue fell short of estimates

Texas governor race tightens in prediction markets, but Abbott remains favored

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Xenon to Report Q3 2026 Financial Results on November 9, 2026

Partager

À lire aussi

Empire State Realty Trust FFO of $0.20 beats by $0.02, revenue of $193.05M beats by $4.34M

AMD Reports Tuesday. Here's the Number That Will Show Whether It's Gaining on Nvidia

Traders rushing into a leveraged ETF to make a bullish bet on the Nasdaq-100 just got burned

People Inc earnings missed by $8.96, revenue fell short of estimates

Texas governor race tightens in prediction markets, but Abbott remains favored

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030